In various malignancies, including PDAC, HCC, and chronic myeloid leukemia (CML), the function of integrins such as α3β1 and α6β1 is modulated by CD147 (130). The gene discussed is BSG; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.